ArticleProceedings of the National Academy of Sciences of the United States of America2016

Anoctamin 2 identified as an autoimmune target in multiple sclerosis.

Burcu Ayoglu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.